Kidney Disease

Treatment could change after study of kidney disease

Published in Blood Weekly, February 19th, 2004

The results of a Detroit, Michigan doctor's study of patients with kidney disease could substantially change how the illness is treated.

The two-year study was led by Robert Provenzano, MD, chief of nephrology at St. John Hospital and Medical Center in Detroit. He studied 600 patients who have kidney disease and anemia at 100 locations across the United States.

Provenzano found that the injectable drug Procrit, which has been used to treat kidney disease and anemia since the 1980s, is effective when administered as infrequently as once a month, The Detroit News reported in a January 20, 2004, story.

Doctors typically require...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2004-02-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry